Susan Thrane

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers.

Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers.

Journal: NPJ vaccines
Published: January 04, 2022

Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.

Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.

Journal: PloS one
Published: April 28, 2021

Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems.

Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems.

Journal: Vaccines
Published: April 16, 2021

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration.

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration.

Journal: Vaccines
Published: January 07, 2021

Structure-Guided Design of a Synthetic Mimic of an Endothelial Protein C Receptor-Binding PfEMP1 Protein.

Structure-Guided Design of a Synthetic Mimic of an Endothelial Protein C Receptor-Binding PfEMP1 Protein.

Journal: mSphere
Published: January 07, 2021

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.

Journal: Nature communications
Published: July 17, 2020

A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice.

A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice.

Journal: Vaccines
Published: June 22, 2020

Virus-like particles displaying major house dust mite allergen Der p 2 for prophylactic allergen immunotherapy.

Virus-like particles displaying major house dust mite allergen Der p 2 for prophylactic allergen immunotherapy.

Journal: Allergy
Published: November 09, 2019

Immunization with virus-like particles conjugated to CIDRα1 domain of Plasmodium falciparum erythrocyte membrane protein 1 induces inhibitory antibodies.

Immunization with virus-like particles conjugated to CIDRα1 domain of Plasmodium falciparum erythrocyte membrane protein 1 induces inhibitory antibodies.

Journal: Malaria journal
Published: October 22, 2019

Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum.

Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum.

Journal: Frontiers in immunology
Published: December 13, 2018

A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine.

A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine.

Journal: Scientific reports
Published: December 03, 2018

Virus-like particle display of HER2 induces potent anti-cancer responses.

Virus-like particle display of HER2 induces potent anti-cancer responses.

Journal: Oncoimmunology
Published: September 28, 2017
Showing 1-12 of 20

Last Updated: 09/26/2026